microRNA 3938 (MIR3938)

microRNA 3938 is a small, non-coding RNA molecule within the human miRNome (hsa-mir-3938), classified as a microRNA. Like other miRNAs, it functions through post-transcriptional gene silencing, mainly by binding to complementary sequences in messenger RNAs. This binding typically results in the repression of gene expression by promoting mRNA destabilization and translational inhibition, affecting key cellular processes such as cell proliferation, differentiation, and survival. Deregulation of miRNA expression, including members of the broader miRNA family, is frequently associated with cancer and other diseases, where they can either suppress or promote tumor-related traits. While miRNAs are established as both biomarkers and therapeutic targets in drug development, there is no specific evidence for interacting drugs, clinical biomarkers, or unique disease associations directly tied to microRNA 3938 as of the current literature. Safety and therapeutic challenges common to the miRNA class include broad and pleiotropic gene regulatory effects and difficulties in targeted delivery. NOTE: The information provided refers primarily to the miRNA family and general mechanisms, as no direct, detailed functional or therapeutic associations for microRNA 3938 were identified in the current sources. If future studies further characterize MIR3938's specific roles or therapeutic utility, these entries may be updated accordingly.

Other names

hsa-mir-3938MIR3938

Therapeutic strategies target miRNAs using antisense oligonucleotides (antagomirs) that inhibit specific miRNAs or miRNA mimics that restore their activity; in general, these modulate endogenous gene silencing functions